Financial statements Przedsiębiorstwo Farmaceutyczne Apexim
Balance sheet of Przedsiębiorstwo Farmaceutyczne Apexim
Company age:
Age:
23 y. 6 m. 27 d.
Share capital:
Share capital:
10 454 694 PLN
Balance sheet data of PRZEDSIĘBIORSTWO FARMACEUTYCZNE APEXIM
|
Year
|
2023
|
|---|---|
| Total assets | 96 262 196,94 |
| A. Fixed assets | 47 273 749,39 |
| B. Current assets | 48 988 447,55 |
| C. Share capital contributions (basic funds) | 0,00 |
| D. Own shares (stocks) | 0,00 |
| Total liabilities | 96 262 196,94 |
| A. Equity | 75 876 254,55 |
| B. Liabilities and provisions for liabilities | 20 385 942,39 |
| I. Long-term liabilities | 0,00 |
| II. Short-term liabilities | 19 011 407,87 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.